Cover Image

Underuse of glucose-lowering medications associated with cardiorenal protection in type 2 diabetes: from delayed initiation to untimely discontinuation

Saved in:

Bibliographic Details
Main Author:	André J. Scheen (Author)
Format:	Book
Published:	Elsevier, 2023-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Untimely papers
by: Bourne, Randolph Silliman, 1886-1918; Oppenheim, James, 1882-1932 [Editor]

Sodium-glucose cotransporter 2 inhibitors: mechanisms of cardiorenal protection: A review
by: Marina V. Leonova
Published: (2024)

It's about time for untimely action
by: Benjamin Gagnon Chainey
Published: (2023)

Make and Let Die: Untimely Sovereignties
by: Biddick, Kathleen
Published: (2016)

Make and Let Die: Untimely Sovereignties
by: Biddick, Kathleen
Published: (2016)

Untimely Initiation of Whole Cow Milk, Stunting, and Related Factors in South Gondar, Ethiopia
by: Yisak H, et al.
Published: (2024)

The Janus face of polypharmacy - overuse versus underuse of medication
by: Kirsten K. Viktil, Hege Salvesen Blix and Åsmund Reikvam

Is Failure the Best Option? An Untimely Reflection on Teaching
by: Stefano Oliverio
Published: (2023)

The consequences of an untimely diagnosed mesiodens: Case report
by: Tomić Slavoljub, et al.
Published: (2007)

Cost-related underuse of medications in older adults: ELSI-Brazil
by: Antônio Ignácio de Loyola Filho, et al.
Published: (2018)

Emerging role of antidiabetic drugs in cardiorenal protection
by: Wen-Jia Fu, et al.
Published: (2024)

Protection against the overuse and underuse of health care - methodological considerations for establishing prioritization criteria and recommendations in general practice
by: Cathleen Muche-Borowski, et al.
Published: (2018)

Medical diaspora: an underused entity in low- and middle-income countries' health system development
by: Seble Frehywot, et al.
Published: (2019)

Harm to Others from Substance Use and Abuse: The Underused Potential in Nationwide Registers
by: Ingunn Olea Lund, et al.
Published: (2015)

Harm to Others from Substance Use and Abuse: The Underused Potential in Nationwide Registers
by: Ingunn Olea Lund, et al.
Published: (2015)

Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review
by: Magnolia Cardona, et al.
Published: (2022)

Cardiorenal and hepatorenal syndrome
by: Anand Bhutada, et al.
Published: (2018)

Less Timely Initiation of Glucose-Lowering Medication Among Younger and Male Patients With Diabetes and Similar Initiation of Blood Pressure-Lowering Medication Across Age and Sex: Trends Between 2015 and 2020
by: Martina Ambrož, et al.
Published: (2022)

Getting by on credit: how district health managers in Ghana cope with the untimely release of funds
by: Ho Maria T, et al.
Published: (2006)

Cardiorenal syndrome type 2: from diagnosis to optimal management
by: De Vecchis R, et al.
Published: (2014)

Oxidative Stress in Cardiorenal System
by: Carlos R. Tirapelli, et al.
Published: (2024)

Categorización del riesgo cardiorenal
by: Boehringer Ingelheim del Ecuador
Published: (2022)

The dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs
by: Jun-Sing Wang, et al.
Published: (2021)

Cardio-Renal Syndrome Type 4: The Correlation Between Cardiorenal Ultrasound Parameters
by: Silvia Lai, et al.
Published: (2016)

Exploring factors influencing initiation, implementation and discontinuation of medications in adults with ADHD
by: Muhammad Umair Khan, et al.
Published: (2021)

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
by: Cankun Zheng, et al.
Published: (2022)

Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment
by: E. V. Reznik, et al.
Published: (2019)

Cardiorenal Syndrome: A Physician Perspective
by: Deepak Jain, et al.
Published: (2017)

Cardiorenal syndrome, a literature review
by: Sergio Orlando Escalona-González, et al.
Published: (2020)

Cardiorenal Crosstalk in Patients with Heart Failure
by: Sara Schukraft, et al.
Published: (2022)

Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis
by: Wenting Xie, et al.
Published: (2022)

Overuse or underuse? Use of healthcare services among irregular migrants in a north-eastern Spanish region
by: Luis Andrés Gimeno-Feliu, et al.
Published: (2021)

Nomogram Model to Predict Cardiorenal Syndrome Type 1 in Patients with Acute Heart Failure
by: Zeyuan Fan, et al.
Published: (2018)

Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation
by: Grazia Maria Virzì, et al.
Published: (2016)

Coexistence of Hemolytic Uremic Syndrome and Type 3 Cardiorenal Syndrome Due to Weil's Disease
by: Nur Özer Şensoy, et al.
Published: (2023)

Elabela Protects Spontaneously Hypertensive Rats From Hypertension and Cardiorenal Dysfunctions Exacerbated by Dietary High-Salt Intake
by: Xavier Sainsily, et al.
Published: (2021)

Untimely Applause Was a Distraction; Comment on "Shanghai Rising: Health Improvements as Measured by Avoidable Mortality since 2000"
by: Yan Fei, et al.
Published: (2015)

Untimely surgery for stent-fracture-related death after transjugular intrahepatic portosystemic shunt: a case report
by: Yunjiang Li, et al.
Published: (2024)

Racial and Ethnic Differences in Initiation and Discontinuation of Antiarrhythmic Medications in Management of Atrial Fibrillation
by: Kipp R, et al.
Published: (2024)

Cardiorenal Involvement in Metabolic Syndrome Induced by Cola Drinking in Rats: Proinflammatory Cytokines and Impaired Antioxidative Protection
by: Matilde Otero-Losada, et al.
Published: (2016)